Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 2Active not recruiting 2Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 6OTHER_GOV 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 9481Triple Negative Breast Neoplasms 635Neoplasms 413Lung Neoplasms 342Prostatic Neoplasms 321Ovarian Neoplasms 299Colorectal Neoplasms 289Neoplasm Metastasis 280Motor Activity 267Carcinoma, Intraductal, Noninfiltrating 231Colonic Neoplasms 193Breast Neoplasms, Male 172Lymphedema 170Melanoma 158Pancreatic Neoplasms 152Breast Carcinoma In Situ 151Carcinoma, Non-Small-Cell Lung 149Uterine Cervical Neoplasms 144Fatigue 140Head and Neck Neoplasms 132Pain 122Breast Cancer Female 122Brain Neoplasms 118Stomach Neoplasms 117Sarcoma 106Depression 105Breast Cancer Lymphedema 101Anxiety Disorders 101Lymphoma 96Cardiotoxicity 89

Interventions

vistusertib 1proto-oncogene protein c-fes-fps 1Transurethral Resection of Bladder 1Hydroxychloroquine 1Fulvestrant 1Everolimus 1Estrogens 1Estradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Estrogen Receptor Positive Breast Cancer × Breast × Clear all
NCT01996046 2025-09-02

FDG PET/CT in Breast Cancer Bone Mets

University of Pennsylvania

Active not recruiting
75 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT06629233 2025-08-29

Tn-Miner

University Ghent

Phase NA Enrolling by invitation
36 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT02238808 2025-06-26

PRESTO

AHS Cancer Control Alberta

Phase 2 Active not recruiting
19 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT02216786 2024-12-02

MANTA

Queen Mary University of London

Phase 2 Completed
333 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT04727632 2024-10-28

[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

University of Utah

Phase EARLY_PHASE1 Terminated
2 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT02414776 2017-09-27

ABC01

Western Regional Medical Center

Phase 1 Terminated
3 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡